Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.64 |
| ▸ | HTT | P42858 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 5/20 | 0.62 |
| ▸ | TACR3 | P29371 | 3/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17923184 | 0.85 | MAPT (0.74) | LMNAKDM4EHTTTP53TACR3 | |
| SCHEMBL6451951 | 0.82 | TACR3 (0.61) | LMNAKDM4EHTTTP53TACR3 | |
| SCHEMBL17413275 | 0.80 | TSHR (0.76) | LMNAKDM4EHTTTP53TACR3 | |
| SCHEMBL6447770 | 0.80 | TACR3 (0.75) | LMNAKDM4EHTTTP53TACR3 | |
| SCHEMBL4469423 | 0.79 | LMNA (0.64) | LMNAKDM4EHTTTP53TACR3 | |
| SCHEMBL28806105 | 0.78 | TACR3 (0.76) | LMNAKDM4EHTTTP53TACR3 | |
| SCHEMBL6448423 | 0.77 | TACR3 (0.70) | LMNAKDM4EHTTTP53TACR3 | |
| SCHEMBL420252 | 0.76 | HPGD (0.72) | LMNAKDM4EHTTTACR3CYP2C9 | |
| SCHEMBL2576382 | 0.76 | KDM4E (0.76) | LMNAKDM4ETP53TACR3CYP2C9 | |
| SCHEMBL6450086 | 0.75 | TACR3 (1.00) | LMNAKDM4EHTTTP53TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1517708-A1 | COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS | Pfizer Products Inc. (US) | 2005-03-30 | — | — | EP | claimed |
| WO-2004000355-A1 | COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS | PFIZER PRODUCTS INC. (US) | 2003-12-31 | — | — | WO | claimed |